B. Hertenstein, L. Hambach, and A. Bacigalupo, Development of leukemia in donor cells after allogeneic stem cell transplantation-a survey of the European Group for Blood and Marrow Transplantation (EBMT), Haematologica, vol.90, issue.7, pp.969-975, 2005.

H. Wang, Y. Liu, and Y. Tsai, Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplant, Ann Hematol, vol.94, issue.5, pp.887-888, 2015.

D. H. Wiseman, Donor Cell Leukemia: a Review, Biol Blood Marrow Transplant, vol.17, issue.6, pp.771-789, 2011.

S. Herold, M. Kuhn, and . Bonin-m-v, Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipient, Leukemia, vol.31, issue.7, pp.1637-1640, 2017.

J. Suárez-gonzález, C. Martínez-laperche, and N. Martínez, Wholeexome sequencing reveals acquisition of mutations leading to the onset of donor cell leukemia after hematopoietic transplantation: a model of leukemogenesis, Leukemia, vol.128, p.2879, 2018.

R. Komrokji, J. J. Ifthikharuddin, and R. E. Felgar, Donor cell myelodysplastic syndrome after allogeneic stem cell transplantation responding to donor lymphocyte infusion: case report and literature review, Am J Hematol, vol.76, issue.4, pp.389-394, 2004.

J. L. Grisolano, R. L. Wesselschmidt, P. G. Pelicci, and T. J. Ley, Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences, Blood, vol.89, issue.2, pp.376-387, 1997.

J. Suárez-gonzález, C. Martínez-laperche, and M. Kwon, Donor cell-derived hematologic neoplasms after hematopoietic stem cell transplantation: a systematic review, Biol Blood Marrow Transplant, vol.24, pp.1505-1513, 2018.

H. Shiozaki, K. Yoshinaga, and T. Kondo, Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source, Bone Marrow Transplant, vol.49, issue.1, pp.102-109, 2014.

R. G. Majzner, H. Mogri, and R. Varadhan, Post-transplantation cyclophosphamide after bone marrow transplantation is not associated with an increased risk of donor-derived malignancy, Biol Blood Marrow Transplant, vol.23, issue.4, pp.612-617, 2017.